Aprogen Medicines Statistics

Total Valuation

KRX:007460 has a market cap or net worth of KRW 216.26 billion. The enterprise value is 567.76 billion.

Market Cap	216.26B
Enterprise Value	567.76B

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:007460 has 291.07 million shares outstanding. The number of shares has increased by 9.40% in one year.

Current Share Class	n/a
Shares Outstanding	291.07M
Shares Change (YoY)	+9.40%
Shares Change (QoQ)	+5.31%
Owned by Insiders (%)	7.35%
Owned by Institutions (%)	2.33%
Float	158.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.44
PB Ratio	0.49
P/TBV Ratio	1.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.78
EV / Sales	3.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.85

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.26.

Current Ratio	1.19
Quick Ratio	0.57
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-1.97
Interest Coverage	-89.66

Financial Efficiency

Return on equity (ROE) is -23.40% and return on invested capital (ROIC) is -10.30%.

Return on Equity (ROE)	-23.40%
Return on Assets (ROA)	-9.37%
Return on Invested Capital (ROIC)	-10.30%
Return on Capital Employed (ROCE)	-18.17%
Revenue Per Employee	612.71M
Profits Per Employee	-237.06M
Employee Count	245
Asset Turnover	0.25
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.11% in the last 52 weeks. The beta is 0.86, so KRX:007460's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-51.11%
50-Day Moving Average	743.64
200-Day Moving Average	1,071.85
Relative Strength Index (RSI)	57.04
Average Volume (20 Days)	1,734,569

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:007460 had revenue of KRW 150.11 billion and -58.08 billion in losses. Loss per share was -225.00.

Revenue	150.11B
Gross Profit	34.30B
Operating Income	-90.32B
Pretax Income	-98.69B
Net Income	-58.08B
EBITDA	-66.02B
EBIT	-90.32B
Loss Per Share	-225.00

Full Income Statement

Balance Sheet

The company has 43.66 billion in cash and 113.70 billion in debt, giving a net cash position of -70.04 billion or -240.63 per share.

Cash & Cash Equivalents	43.66B
Total Debt	113.70B
Net Cash	-70.04B
Net Cash Per Share	-240.63
Equity (Book Value)	440.09B
Book Value Per Share	559.82
Working Capital	21.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -44.99 billion and capital expenditures -12.67 billion, giving a free cash flow of -57.66 billion.

Operating Cash Flow	-44.99B
Capital Expenditures	-12.67B
Free Cash Flow	-57.66B
FCF Per Share	-198.11

Full Cash Flow Statement

Margins

Gross margin is 22.85%, with operating and profit margins of -60.17% and -38.69%.

Gross Margin	22.85%
Operating Margin	-60.17%
Pretax Margin	-65.74%
Profit Margin	-38.69%
EBITDA Margin	-43.98%
EBIT Margin	-60.17%
FCF Margin	n/a

Dividends & Yields

KRX:007460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.40%
Shareholder Yield	-9.40%
Earnings Yield	-26.86%
FCF Yield	-26.66%

Stock Splits

The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Dec 28, 2022
Split Type	Reverse
Split Ratio	0.3333333333

Scores

KRX:007460 has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.05
Piotroski F-Score	n/a